Methotrexate from Canada
Methotrexate is a folic acid antagonist featuring pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. It qualifies for HTS 2934.99.30.00 as an aromatic heterocyclic drug compound used in rheumatoid arthritis and cancer treatments.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Submit Type II Drug Master Files and bioequivalence data for generic API approval during import clearance
• Provide impurity profiles and chiral purity certificates since it's a single enantiomer drug substance
• Include cytotoxic hazard labeling and UN shipping declarations for safe transport compliance